{"nct_id":"NCT04788615","title":"Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2021-07-23","start_date_type":"ACTUAL","primary_completion_date":"2025-11-11","primary_completion_date_type":"ESTIMATED","completion_date":"2026-02-13","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["NVS"]}